These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22109004)

  • 21. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer screening in women: An integrative literature review.
    Ravert PK; Huffaker C
    J Am Acad Nurse Pract; 2010 Dec; 22(12):668-73. PubMed ID: 21129075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the therapeutic efficacy of a VEGFR2-blocking antibody using sodium-iodide symporter molecular imaging in a tumor xenograft model.
    Cheong SJ; Lee CM; Kim EM; Uhm TB; Jeong HJ; Kim DW; Lim ST; Sohn MH
    Nucl Med Biol; 2011 Jan; 38(1):93-101. PubMed ID: 21220132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synergistic use of epidermal growth factor and 5-fluorouracil for the treatment of human colorectal cancer in BALB/C nude mice subcutaneous xenograft model].
    Ye L; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):69-72. PubMed ID: 19145509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin.
    Fradet A; Sorel H; Bouazza L; Goehrig D; Dépalle B; Bellahcène A; Castronovo V; Follet H; Descotes F; Aubin JE; Clézardin P; Bonnelye E
    Cancer Res; 2011 Sep; 71(17):5728-38. PubMed ID: 21734015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
    Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
    Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
    Schubert A; Hawighorst T; Emons G; Gründker C
    Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lignans are accessible to human breast cancer xenografts in athymic mice.
    Saarinen NM; Power KA; Chen J; Thompson LU
    Nutr Cancer; 2008; 60(2):245-50. PubMed ID: 18444157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Cancer Screening in Elderly Women: Primum Non Nocere.
    Jatoi I; Miller AB
    JAMA Surg; 2015 Dec; 150(12):1107-8. PubMed ID: 26465234
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening high risk women with MRI alone?
    Sardanelli F; Santoro F; Podo F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S137-8. PubMed ID: 23083564
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast imaging pioneer sheds light on screening technology.
    Conant E
    Oncology (Williston Park); 2010 Oct; 24(11):1007. PubMed ID: 21155449
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Chen H; Han J; Wang D; Zhang Y; Li X; Chen X
    Front Genet; 2021; 12():700086. PubMed ID: 34646298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitive and high resolution subcutaneous fluorescence in vivo imaging using upconversion nanoparticles and microarrays.
    Li X; Li Z; Gan W; Wang T; Zhao S; Lu Y; Cheng J; Huang G
    Analyst; 2013 Jul; 138(13):3711-8. PubMed ID: 23687650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of FCC-NMRD relaxometry for early detection and characterization of ex-vivo murine breast cancer.
    Di Gregorio E; Ferrauto G; Lanzardo S; Gianolio E; Aime S
    Sci Rep; 2019 Mar; 9(1):4624. PubMed ID: 30874603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In defense of screening for breast cancer with magnetic resonance imaging.
    Keller DL
    JAMA Intern Med; 2014 Aug; 174(8):1417. PubMed ID: 25090183
    [No Abstract]   [Full Text] [Related]  

  • 38. In defense of screening for breast cancer with magnetic resonance imaging--reply.
    Hwang ES
    JAMA Intern Med; 2014 Aug; 174(8):1417-8. PubMed ID: 25090184
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary imaging results and SAR analysis of a microwave imaging system for early breast cancer detection.
    Dagheyan AG; Molaei A; Obermeier R; Martinez-Lorenzo J
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():1066-1069. PubMed ID: 28268509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI scanning increases eightfold in Canadian women with breast cancer.
    Wise J
    BMJ; 2015 Sep; 351():h5088. PubMed ID: 26415937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.